A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer Meeting Abstract
| Authors: | Yaeger, R.; Langer, C. J.; Ruffinelli, J. C.; Fakih, M.; Furqan, M.; Machiels, J. P. H.; Saportas, Y.; Nolte-Hippenmeyer, J.; Chan, E.; Xia, C.; Masuishi, T. |
| Abstract Title: | A phase 1b study of sotorasib combined with panitumumab as second-line treatment of KRAS G12C-mutated colorectal cancer |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500373 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.128 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 128 -- Source: Wos |
